about
Hypothesis driven development of new adjuvants: short peptides as immunomodulatorsThe oligodeoxynucleotide sequences corresponding to never-expressed peptide motifs are mainly located in the non-coding strand.Proposing low-similarity peptide vaccines against Mycobacterium tuberculosisDescribing the hexapeptide identity platform between the influenza A H5N1 and Homo sapiens proteomes.Comparing the similarity of different groups of bacteria to the human proteomeSelfness-nonselfness in designing an anti-B19 erythrovirus vaccineIncreasing the efficacy of tumor cell vaccines by enhancing cross primingInnate immunity against molecular mimicry: Examining galectin-mediated antimicrobial activity.Measles virus hemagglutinin epitopes are potential hotspots for crossreactions with immunodeficiency-related proteins.Peptide sharing between Bordetella pertussis proteome and human sudden death proteins: a hypothesis for a causal link.West Nile virus diagnosis and vaccination: using unique viral peptide sequences to evoke specific immune responses.HCV: Written in our DNA.EBV-Associated Cancer and Autoimmunity: Searching for Therapies.Clustering of rare peptide segments in the HCV immunome.Searching for an effective, safe and universal anti-HIV vaccine: Finding the answer in just one short peptide.A Therapeutic Peptide Vaccine Against PCSK9.The self/nonself issue: A confrontation between proteomes.Sequence uniqueness as a molecular signature of HIV-1-derived B-cell epitopes.Pentapeptide sharing between Corynebacterium diphtheria toxin and the human neural protein network.Bacterial peptides are intensively present throughout the human proteome.Evidence for a vast peptide overlap between West Nile virus and human proteomes.A qualitative description of the peptide sharing between poliovirus and Homo sapiens.Development of vaccine for dyslipidemia targeted to a proprotein convertase subtilisin/kexin type 9 (PCSK9) epitope in mice.
P2860
Q27023844-1BBD93BB-E120-4C7B-8A18-C8DF5541ADE5Q33636782-5532A2C5-96FF-4D9D-9827-C594510BA487Q33961091-82C8D4CC-B4B3-41C9-A378-134C4BC6237FQ34144218-BF971965-1828-45CE-B4D3-CD4591F99402Q34256148-2DCF90B1-FF28-4026-BBE2-51A24EFC3188Q35714389-B26108DA-B19E-4696-8A6A-1D15ABE43609Q36288105-54BCFF79-DAFF-4A73-8595-5AD46F216F55Q38635983-63B800E7-2496-4D52-A2C1-C77EEA3CB6DFQ39019015-E5D7032F-BDB2-4B4D-A554-55CEA41FEF70Q39375013-8B8FF2CA-F75E-4628-9729-EF0A29C9B812Q40269573-AAFD98C0-B647-4D15-8529-31DDA5F834FDQ40751217-7707496F-BEBE-4FF3-A156-597618585C42Q41012612-87F64E71-C26B-4A80-8D53-5637BBBEF069Q41819793-6D6D165D-295F-4978-8111-FF32288894CCQ41825435-3C42489F-9424-4491-B9C3-3E04909905EFQ41925912-E06EB2A5-D65D-45E6-98DC-D8D2DCBEC822Q42155059-0D26EB17-88E3-46E8-AD4A-7DCDE39E6E83Q42636440-6853CD67-36CB-424E-AB08-81B0EA618B66Q42676705-9B4BEA98-C0EB-46A5-A4BE-34882F2F604FQ42731026-6821195C-C77A-409E-BCBF-919B4E3F9F1FQ42984053-6112E735-B1DD-48D3-9875-EF94903A9140Q44368878-323FB9C5-16E9-48E9-9EAB-4B6EB4E87825Q50041681-6B850C46-EBDE-4CA7-8604-08F0C76B8306
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
"Self-nonself" peptides in the design of vaccines.
@en
"Self-nonself" peptides in the design of vaccines.
@nl
type
label
"Self-nonself" peptides in the design of vaccines.
@en
"Self-nonself" peptides in the design of vaccines.
@nl
prefLabel
"Self-nonself" peptides in the design of vaccines.
@en
"Self-nonself" peptides in the design of vaccines.
@nl
P1476
"Self-nonself" peptides in the design of vaccines
@en
P2093
Darja Kanduc
P304
P356
10.2174/138161209789105135
P50
P577
2009-01-01T00:00:00Z